Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLUT4 is a facilitative glucose transporter protein encoded by the SLC2A4 gene, primarily found in adipose tissue and striated muscle. It belongs to the Class 1 glucose transporters and the major facilitator superfamily, featuring a 12-transmembrane domain structure. GLUT4 plays a critical role in glucose metabolism by mediating insulin-stimulated glucose uptake into muscle and fat cells via ATP-independent facilitative diffusion. Uniquely, GLUT4 is predominantly stored in intracellular vesicles in the absence of insulin or exercise. Upon insulin stimulation or during exercise, these vesicles translocate to the plasma membrane, increasing glucose transport into the cell. This process involves a complex signaling cascade initiated by insulin binding to its receptor, activating PI3K and AKT, which triggers vesicle fusion. After stimulation, GLUT4 is endocytosed. Dysregulation of GLUT4 expression and function, including mutations or overexpression, is linked to metabolic disorders such as increased fat storage, glucose homeostasis issues, and insulin resistance, making it an important target for understanding and potentially treating these conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose transporter type 4 (GLUT4).